EMORY UNIVERSITY
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1836-12-10
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.emory.edu
Bioenergetic Effect of Pioglitazone in CLD-PH
Phase 2
Recruiting
- Conditions
- Pulmonary Hypertension Due to Lung DiseasesPulmonary Hypertension
- Interventions
- First Posted Date
- 2024-03-29
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- Emory University
- Target Recruit Count
- 20
- Registration Number
- NCT06336798
- Locations
- πΊπΈ
Emory Healthcare System, Atlanta, Georgia, United States
Chaplain-Delivered Compassion Meditation to Improve Spiritual Care of Patients Receiving Stem Cell Transplantation
Not Applicable
Recruiting
- Conditions
- Multiple MyelomaLymphoma
- Interventions
- Other: Best PracticeProcedure: Spiritual Therapy
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2024-08-26
- Lead Sponsor
- Emory University
- Target Recruit Count
- 50
- Registration Number
- NCT06328699
- Locations
- πΊπΈ
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
Arginine and Whole Brain Radiation Therapy for the Treatment of Patients With Brain Metastases
Early Phase 1
Not yet recruiting
- Conditions
- Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Solid Neoplasm
- Interventions
- Dietary Supplement: ArginineProcedure: Biospecimen CollectionProcedure: Computed TomographyProcedure: Magnetic Resonance ImagingProcedure: SpectroscopyRadiation: Whole-Brain Radiotherapy
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2024-07-18
- Lead Sponsor
- Emory University
- Target Recruit Count
- 10
- Registration Number
- NCT06328686
- Locations
- πΊπΈ
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
Phase 1
Not yet recruiting
- Conditions
- Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8Anatomic Stage IIIC Breast Cancer AJCC v8
- Interventions
- First Posted Date
- 2024-03-21
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Emory University
- Target Recruit Count
- 18
- Registration Number
- NCT06324240
- Locations
- πΊπΈ
Grady Health System, Atlanta, Georgia, United States
πΊπΈEmory University Hospital Midtown, Atlanta, Georgia, United States
πΊπΈEmory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States
Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)
Phase 2
Recruiting
- Conditions
- Multi-Drug Resistant Organism Colonization
- Interventions
- Drug: Allogeneic Microbiota in Glycerol (9%) (AMG)
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Emory University
- Target Recruit Count
- 200
- Registration Number
- NCT06321536
- Locations
- πΊπΈ
Emory University Hospital, Atlanta, Georgia, United States
Gamma Sensory Flicker for Parkinson's Disease Patients With Freezing of Gait
Not Applicable
Recruiting
- Conditions
- Gait Disorders, NeurologicParkinson Disease
- Interventions
- Other: Sham TherapyDevice: David Delight Plus Device
- First Posted Date
- 2024-03-06
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Emory University
- Target Recruit Count
- 28
- Registration Number
- NCT06295458
- Locations
- πΊπΈ
Emory Movement Disorders Center, Atlanta, Georgia, United States
Pectoralis Minor Release Versus Non-release in RSA
Not Applicable
Not yet recruiting
- Conditions
- Reverse Total Shoulder ArthroplastyAdvanced Glenohumeral OsteoarthritisRotator Cuff Tear Arthropathy
- Interventions
- Procedure: Pectoralis Minor ReleaseProcedure: RSA
- First Posted Date
- 2024-03-05
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Emory University
- Target Recruit Count
- 30
- Registration Number
- NCT06292169
- Locations
- πΊπΈ
Emory Clinic, Atlanta, Georgia, United States
πΊπΈEmory Healthcare Orthopaedics and Spine Center, Atlanta, Georgia, United States
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
Phase 3
Recruiting
- Conditions
- Postoperative Urinary Tract Infection
- Interventions
- Other: Control Group
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2025-03-11
- Lead Sponsor
- Emory University
- Target Recruit Count
- 212
- Registration Number
- NCT06257576
- Locations
- πΊπΈ
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States
πΊπΈEmory University Hospital Midtown, Atlanta, Georgia, United States
πΊπΈEmory University Hospital (EUH), Atlanta, Georgia, United States
Pre-operative Atezolizumab in Patients with Resectable, Human Papillomavirus Related Oropharyngeal Carcinoma
Phase 2
Recruiting
- Conditions
- Oropharynx Cancer, Stage I
- Interventions
- Procedure: Transoral Surgery with cervical lymphadenctomy (neck dissection)Procedure: Computed TomographyProcedure: Magnetic Resonance Imaging
- First Posted Date
- 2024-02-12
- Last Posted Date
- 2025-03-30
- Lead Sponsor
- Emory University
- Target Recruit Count
- 20
- Registration Number
- NCT06254911
- Locations
- πΊπΈ
Emory University Hospital Midtown, Atlanta, Georgia, United States
Precision Resuscitation With Crystalloids in Sepsis
Not Applicable
Recruiting
- Conditions
- Sepsis
- Interventions
- Other: Algorithm Alarm- CrystalloidsOther: Standard of Care
- First Posted Date
- 2024-02-12
- Last Posted Date
- 2025-03-14
- Lead Sponsor
- Emory University
- Target Recruit Count
- 2002
- Registration Number
- NCT06253585
- Locations
- πΊπΈ
Emory Midtown Hospital, Atlanta, Georgia, United States
πΊπΈEmory Saint Joseph's Hospital, Atlanta, Georgia, United States
πΊπΈEmory Healthcare System, Atlanta, Georgia, United States